Cumberland Pharmaceuticals Stock Today

CPIX Stock  USD 1.20  0.02  1.69%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 43

 
High
 
Low
Below Average
Cumberland Pharmaceuticals is trading at 1.20 as of the 14th of November 2024; that is 1.69 percent increase since the beginning of the trading day. The stock's open price was 1.18. Cumberland Pharmaceuticals has about a 43 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Cumberland Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 15th of October 2024 and ending today, the 14th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
11th of August 2009
Category
Healthcare
Classification
Health Care
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company has 14.1 M outstanding shares of which 76.74 K shares are currently shorted by private and institutional investors with about 2.31 trading days to cover. More on Cumberland Pharmaceuticals

Moving together with Cumberland Stock

  0.82VALN Valneva SE ADRPairCorr

Moving against Cumberland Stock

  0.68VERA Vera TherapeuticsPairCorr
  0.68DRUG Bright Minds BiosciencesPairCorr
  0.64DMAC DiaMedica TherapeuticsPairCorr
  0.64DNLI Denali TherapeuticsPairCorr
  0.61VCYT VeracytePairCorr
  0.58DSGN Design TherapeuticsPairCorr

Cumberland Stock Highlights

Thematic Ideas
(View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Drugs, Health Management, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.580.4837
Fairly Up
Slightly volatile
Gross Profit Margin0.940.7218
Significantly Up
Slightly volatile
Total Current Liabilities16.8 M28 M
Way Down
Slightly volatile
Non Current Liabilities Total13.1 M24.5 M
Way Down
Slightly volatile
Total Assets88.1 M81.8 M
Significantly Up
Slightly volatile
Total Current Assets60.5 M35.7 M
Way Up
Pretty Stable
Debt Levels
Cumberland Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cumberland Pharmaceuticals' financial leverage. It provides some insight into what part of Cumberland Pharmaceuticals' total assets is financed by creditors.
Liquidity
Cumberland Pharmaceuticals currently holds 18.43 M in liabilities with Debt to Equity (D/E) ratio of 0.5, which is about average as compared to similar companies. Cumberland Pharmaceuticals has a current ratio of 1.76, which is within standard range for the sector. Note, when we think about Cumberland Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.

Change To Account Receivables

3.58 Million
Cumberland Pharmaceuticals (CPIX) is traded on NASDAQ Exchange in USA. It is located in 1600 West End Avenue, Nashville, TN, United States, 37203 and employs 91 people. Cumberland Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.91 M. Cumberland Pharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 14.1 M outstanding shares of which 76.74 K shares are currently shorted by private and institutional investors with about 2.31 trading days to cover. Cumberland Pharmaceuticals currently holds about 18.22 M in cash with 6.09 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Cumberland Pharmaceuticals Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Cumberland Pharmaceuticals is $16.91 Million. Cumberland Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Cumberland Ownership Details

Cumberland Stock Institutional Holders

InstituionRecorded OnShares
Ubs Group Ag2024-06-30
6.9 K
Tower Research Capital Llc2024-06-30
6.6 K
Morgan Stanley - Brokerage Accounts2024-06-30
5.3 K
Oakworth Capital Inc2024-09-30
3.1 K
Innealta Capital, Llc2024-06-30
948
Citadel Advisors Llc2024-06-30
834
Advisor Group Holdings, Inc.2024-06-30
100.0
Bank Of America Corp2024-06-30
67.0
Royal Bank Of Canada2024-06-30
47.0
Renaissance Technologies Corp2024-06-30
538.2 K
Vanguard Group Inc2024-06-30
374.3 K
View Cumberland Pharmaceuticals Diagnostics

Cumberland Pharmaceuticals Historical Income Statement

At this time, Cumberland Pharmaceuticals' Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 701.3 K in 2024, whereas Selling General Administrative is likely to drop slightly above 8.9 M in 2024. View More Fundamentals

Cumberland Stock Against Markets

Cumberland Pharmaceuticals Corporate Management

James HermanChief Compliance Officer and VP of National AccountsProfile
John HammChief OfficerProfile
Todd AnthonyVice DevelopmentProfile
Adam MostafaManaging DirectorProfile
Erin GullSenior AssociateProfile
Jean MarstillerSenior SecretaryProfile
Chris BittermanVice MarketingProfile

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.